The C. DIFFICILE TOX-B TEST is intended for use in conjunction with the tissue culture cytotoxicity assay for the detection of C. difficile toxin B in patient specimens. The test is to be…
The C. DIFFICILE TOX-B TEST is intended for use in conjunction with the tissue culture cytotoxicity assay for the detection of C. difficile toxin B in patient specimens. The test is to be used as an aid in the diagnosis of C. difficile disease and results should be considered in conjunction with patient history.
Who Else Makes It
Registered in Jiangsu.
Record
Regulatory record for C. Difficile TOX-B Test | Listed by | Techlab, Inc., United States |
| FDA product code | LLH |
| Device type | Reagents, Clostridium Difficile Toxin |
| Device class | Class 1 |
| Regulation | 21 CFR 866.2660 |
| Establishment | Manufacturer |
| Record published | 2020-01-24 |
| Record revised | 2023-08-15 (version 2) |
Specifications
Specifications | MRI safety | Labeling does not contain MRI Safety Information |
| Single use | Yes |
| Prescription | Prescription only |
| Supplied as a kit | Yes |
| Label carries | lot or batch number, expiry date |
| Distribution end date | 2021-05-04 |
Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.